Olympus Private placement posts...
Message 21492030
Message 21287188
(On April 29, 2005 they closed @ 2.13 Euros, and 2.63 Euros on May 3, 2005)
finance.yahoo.com
Best of luck,
SS
>>>
MacroPore Biosurgery to Raise $11.0 Million from Equity Placement
San Diego, CA, May 2, 2005 - MacroPore Biosurgery, Inc. (Frankfurt: XMP) today announced it has signed a definitive agreement to raise $11.0 million from the sale of 1.1 million shares of common stock at $10.00 per share. The transaction will be completed on or before May 31, 2005. As part of the agreement, the investor has been granted an option that expires December 31, 2006 to purchase an additional 2.2 million shares of common stock at $10.00 per share. In addition, the investor has been offered a voting seat on MacroPore’s Board of Directors. MacroPore will use these funds primarily to support the research and development of its regenerative cell technology.
About MacroPore Biosurgery, Inc.
MacroPore Biosurgery specializes in the discovery and development of regenerative medicine therapies. The Company has two principal technology platforms, adipose-derived regenerative cells and bioresorbable implants. The Company is developing treatments for cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery using stem and regenerative cells from adipose tissue. This tissue is the richest and most accessible known source for regenerative cells. To facilitate the processing and delivery of adipose-derived regenerative cells, the Company is designing a proprietary point-of-care system, Celution™, to isolate and concentrate a patient’s own regenerative cells in real-time. Additionally, MacroPore Biosurgery manufactures the HYDROSORB™ family of FDA-cleared bioresorbable spine and orthopedic implants, which are distributed exclusively through Medtronic, Inc. For more information, please visit macropore.com.
Contact:
Stefanie Bacher
Medien/Investoren International
Tel. +1-858-736-5485
sbacher@macropore.com
Tom Baker
Medien/US-Investoren
Tel. +1-858-458-0900
tbaker@macropore.com |
